Direct oral anticoagulants (DOACs)

DRUG2 trials

Sponsors

Canadian Network for Observational Drug Effect Studies, CNODES, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Acute Ischemic StrokeAll-cause MortalityAtrial FibrillationAtrial Fibrillation (AF)Intracerebral HemorrhageIschemic StrokeMajor BleedMyocardial Infarction

Phase 4

Oral Anticoagulation After Stroke With Prior ICH in Subjects With AF

Not yet recruitingNCT07609654

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAcute Ischemic Stroke, Atrial Fibrillation (AF), Intracerebral Hemorrhage

Start: 2026-06-01End: 2029-09-01Target: 852Updated: 2026-05-27

Unknown Phase

Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)

CompletedNCT03596502

Canadian Network for Observational Drug Effect Studies, CNODESAll-cause Mortality, Atrial Fibrillation, Ischemic Stroke +3

Start: 2018-02-01End: 2018-12-01Updated: 2024-09-19

Related Papers

Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study

CMAJ Open2020-10-0127 citations